Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 14, 2013

Antares, MannKind, Teva

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

FILINGS Antares gets Otrexup approval . . . read more MannKind resubmits Afrezza . . . read more Teva To Launch TOBI . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters